Showing results (331-340 of 352) with videos related to
Sort By:
Pageof 36
Human Mutation|January 1, 1997
Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiencyJ Villard, W Reith, E Barras, et al.Nature Genetics|November 7, 1998
A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patientsK Masternak, E Barras, M Zufferey, et al.Hormone Research|August 20, 2009
Is the response to growth hormone in short children born small for gestational age dependent on genetic or maternal factors?Otto Mehls, A Lindberg, M Bettendorf, et al.The Journal of Experimental Medicine|August 22, 2001
Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expressionS Landmann, A Mühlethaler-Mottet, L Bernasconi, et al.Clinical Neuroradiology|December 25, 2015
The Derivo Embolization Device, a Second-Generation Flow Diverter for the Treatment of Intracranial Aneurysms, Evaluated in an Elastase-Induced Aneurysm ModelD Ley, R Mühl-Benninghaus, U Yilmaz, et al.American Journal of Human Genetics|May 11, 2006
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathyS Ferdinandusse, P Kostopoulos, S Denis, et al.Molecular and Cellular Biology|May 4, 2004
The transcription factor RFX3 directs nodal cilium development and left-right asymmetry specificationE Bonnafe, M Touka, A AitLounis, et al.The Annals of Thoracic Surgery|November 8, 2021
Successful Lung Transplantation for Severe Post-COVID-19 Pulmonary FibrosisDavid J Hall, Jefree J Schulte, Erik E Lewis, et al.European Radiology|May 9, 2013
Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO)L Pierot, C Cognard, D Herbreteau, et al.Human Molecular Genetics|May 23, 1998
Genetic and molecular definition of complementation group D in MHC class II deficiencyM C Fondaneche, J Villard, W Wiszniewski, et al.Pageof 36